Lyell is focused on advancing next-generation CAR T cell therapies with the potential to deliver higher response rates and longer duration of responses for patients with hematologic malignancies and ...

STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.

BioUtah, the trade association, common voice, and flag bearer for Utah's life sciences industry, today announced that it will ...

Jay Rosanelli, CEO at Syenex, added: "This joint effort showcases the role of collaborative science in accelerating the ...

Hospitals Open For Now As LA Fires Worsen: Hospitals in Los Angeles County remained operational as of Wednesday evening, though several health systems have shuttered clinical locations and physician ...

Shareholders have asked for details about how UnitedHealth Group's tactics that curb care have affected patients. This comes as a Texas doctor details her frustrating experience with the insurer.

FY2024 revenue up 7% YoY, driven by international demand. Find out why I am upgrading CTKB stock from Hold to Buy.

NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will present at the 43 rd ...

Biomedicines ("Generate") today announced that Mike Nally, Chief Executive Officer, will provide an update on the company's ...

J.P. Morgan releases its annual look-ahead days before the entire biopharma industry descends on San Francisco for the annual ...

City officials are particularly vigilant following the slaying of a top healthcare executive a month ago in New York City.